
Eric James Mallack MD
Pediatric Neurology Attending. NIH/NINDS K12 NSADA Scholar
505 E 70th StFl 3New York, NY 10021
Overview of Dr. Mallack
Dr. Eric Mallack is a Child Neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Rockefeller University Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and New York-Presbyterian Hospital. He received his medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 5 years. He is one of 2 doctors at Rockefeller University Hospital and one of 5 doctors at Memorial Sloan Kettering Cancer Center who specialize in Child Neurology. He has more than 10 publications and over 500 citings.
Education & Training
- Massachusetts General HospitalPost-Doctoral Fellowship, 2017 - 2020
- New York-Presbyterian HospitalPost-Doctoral Fellowship, 2017 - 2020
- New York Presbyterian Hospital (Cornell Campus)Chief Residency, Child Neurology, 2016 - 2017
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Child Neurology, 2014 - 2017
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2012 - 2016
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2012 - 2014
- University of Pennsylvania School of MedicineMaster of Bioethics (MBE), 2009 - 2012
- Lewis Katz School of Medicine at Temple UniversityClass of 2012
- University of ScrantonA.B., Philosophy, Biomathematics, 2004 - 2008
Certifications & Licensure
- MD State Medical License 2023 - 2027
- NY State Medical License 2014 - 2026
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- K12 Neurological Sciences Academic Development Award (NSADA, K12 Physician Scientist Award) NIH/NINDS, 2017
Publications & Presentations
PubMed
- Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial.Ángeles García-Cazorla, Caroline Sevin, Juliana Ribeiro Constante, Elise Yazbeck, Hendrik Rosewich
Eclinicalmedicine. 2025-06-01 - 1 citationsA novel missense variant in HIKESHI: Clinical phenotype, in vitro functional testing, and potential for gene therapy.Eric J Mallack, Chengbing Wang, Ji-Sun Kim, M Elizabeth Ross
American Journal of Medical Genetics. Part A. 2024-11-01 - 14 citationsConsensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States.Laura A Adang, Joshua L Bonkowsky, Jaap Jan Boelens, Eric Mallack, Rebecca Ahrens-Nicklas
Cytotherapy. 2024-07-01
Press Mentions
- Passage Bio to Showcase GM1 Gangliosidosis and Krabbe Clinical Programs at 2022 WORLDSymposium, February 7 – 11January 31st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: